rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Steven M. Klosk

Director

Company insider

Files Form 4 as: Director, Lisata Therapeutics; Director, Bolt Projects Holdings; President & CEO, Cambrex.

Every Form 4 they filed

In numbers

Trades disclosed
258
Buys
2
Sells
49
Bought
$129K
Sold
$72.7M
Companies
3
Companies where not an officer
2
First trade
6 Feb 2004
Last trade
9 Jan 2026
Last filed
13 Jan 2026

Companies traded

Where they are an officer
CambrexDirector, Officer · last 4 Dec 20191 buy · 49 sells
Everywhere else they filed: board seats, 10% stakes, other companies
LSTA Lisata TherapeuticsDirector · Biotechnology · last 9 Jan 20261 buy · 0 sells
Bolt Projects HoldingsDirector · last 25 Nov 20240 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
9 Jan 2026filed 13 Jan 2026LSTA Lisata TherapeuticsBiotechnologySEC FORM 4 Code A—30,456 at $0.00filing
9 Jan 2026filed 13 Jan 2026LSTA Lisata TherapeuticsBiotechnologySEC FORM 4 Code A—30,456 at $0.00filing
9 Jan 2025filed 13 Jan 2025LSTA Lisata TherapeuticsBiotechnologySEC FORM 4 Code A—15,789 at $0.00filing
25 Nov 2024filed 27 Nov 2024Bolt Projects HoldingsSEC FORM 4 Code A—22,500 at $0.00filing
25 Nov 2024filed 27 Nov 2024Bolt Projects HoldingsSEC FORM 4 Code A—15,000 at $0.00filing
13 Aug 2024filed 15 Aug 2024Bolt Projects Holdingsoption or derivativeSEC FORM 4 Code M—35,000filing
13 Aug 2024filed 15 Aug 2024Bolt Projects HoldingsSEC FORM 4 Code M—35,000filing
9 Jan 2024filed 11 Jan 2024LSTA Lisata TherapeuticsBiotechnologySEC FORM 4 Code A—19,480 at $0.00filing
9 Jan 2023filed 11 Jan 2023LSTA Lisata TherapeuticsBiotechnologySEC FORM 4 Code A—20,000 at $0.00filing
10 Jan 2022filed 12 Jan 2022LSTA Lisata TherapeuticsBiotechnologySEC FORM 4 Code A—65,430 at $0.00filing
11 Jan 2021filed 12 Jan 2021LSTA Lisata TherapeuticsBiotechnologySEC FORM 4 Code A—37,735 at $0.00filing
13 Jan 2020filed 14 Jan 2020LSTA Lisata TherapeuticsBiotechnologySEC FORM 4 Code A$60K18,292 at $3.28filing
4 Dec 2019filed 5 Dec 2019Cambrexoption or derivativeSEC FORM 4 Code M—50,000 at $0.00filing
4 Dec 2019filed 5 Dec 2019Cambrexoption or derivativeSEC FORM 4 Code M—50,000 at $0.00filing
4 Dec 2019filed 5 Dec 2019Cambrexoption or derivativeSEC FORM 4 Code M—38,000 at $0.00filing
4 Dec 2019filed 5 Dec 2019Cambrexoption or derivativeSEC FORM 4 Code M—30,000 at $0.00filing
4 Dec 2019filed 5 Dec 2019CambrexSEC FORM 4 Code M$2.1M50,000 at $41.36filing
4 Dec 2019filed 5 Dec 2019CambrexSEC FORM 4 Code M$2.0M50,000 at $40.65filing
4 Dec 2019filed 5 Dec 2019CambrexSEC FORM 4 Code M$1.7M38,000 at $45.64filing
4 Dec 2019filed 5 Dec 2019CambrexSEC FORM 4 Code M$1.6M30,000 at $53.61filing

Sectors

Health Care1
Not placed50

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.